Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.

Revenue
+21.7%
EPS
−24.2%
Free cash flow
+51.0%

Quarter to September 2026, against a year earlier

465.68 16.42 −3.41%
Market cap
$162.4B
P/E
55.7×
Fwd P/E
49.8×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

70.71 55.08 44.99 48.64
P/S ratio
20.08 15.46 12.76 12.26
P/FCF ratio
81.16 56.80 43.08 38.94
P/Operating CF
226.48 179.41 132.72 115.93
P/B ratio
11.27 9.30 7.70 8.80
EV/Sales
19.49 15.03 12.29 11.91
EV/EBITDA
54.16 40.20 31.88 33.34
EV/FCF
78.77 55.23 41.49 37.84
Current Ratio
4.87 4.61 4.96 3.33
Net Debt/EBITDA
(5.39) (4.32) (4.37) (5.08)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
1.41% 1.82% 2.22% 2.06%
Free Cash Flow Yield
1.23% 1.76% 2.32% 2.57%
Free Cash Flow per Share
2.05 2.41 2.68 3.18
Book value per Share
50.27 49.58 51.67 46.18
Free Cash Flow
730.00 854.60 948.40 1,111.00
EV/EBIT
66.61 49.36 39.29 41.98
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026